People living with type 2 diabetes face several significant health challenges. The condition, which affects more than 10% of ...

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate for the ...

The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...

The most prevalent kind of diabetes is type 2, and symptoms usually develop over several years ... and retina problems,” he ...

New data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have ...

The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million—over four ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

More than 800 million adults have diabetes worldwide, almost twice as many as previously thought, research has suggested.

Global adult diabetes cases have doubled to more than 800 million during the past three decades, far exceeding previous ...

Groundbreaking study reveals significant rise in diabetes prevalence, particularly in low- and middle-income nations - ...